CA
caroline a. heckman
Institute for Molecular Medicine Finland – FIMM, HiLIFE – Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki
Finland
Authors
- CT
ciara tierney
Department of Hematology, Mater Misericordiae University Hospital
Ireland
- JT
jing tang
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki
Finland
- JJ
juho j. miettinen
Institute for Molecular Medicine Finland – FIMM, HiLIFE – Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki
Finland
- ML
minxia liu
Institute for Molecular Medicine Finland – FIMM, HiLIFE – Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki
Finland
- PK
pankaj k. singh
The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center
United States
- PO
peter o’gorman
Department of Hematology, Mater Misericordiae University Hospital
Ireland
- RJ
ryan j. king
The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center
United States
- YW
yinyin wang
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki
Finland
- AP
alun parsons
Institute for Molecular Medicine Finland – FIMM, HiLIFE – Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki
Finland
- DB
despina bazou
Department of Hematology, Mater Misericordiae University Hospital
Ireland
- FQ
fang qiu
Department of Biostatistics, University of Nebraska Medical Center
United States
